Safety of TNF-α inhibitors during IBD pregnancy: a systematic review

BACKGROUND: Tumor necrosis factor (TNF)-α inhibitors are increasingly being used in inflammatory bowel disease (IBD). Because this chronic intestinal disorder often affects women of fertile age, it is essential to assess the effect of biologics on pregnancy outcome. METHODS: We performed a systemati...

Descripción completa

Detalles Bibliográficos
Autores principales: Nielsen, Ole Haagen, Loftus Jr, Edward V, Jess, Tine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3734216/
https://www.ncbi.nlm.nih.gov/pubmed/23902720
http://dx.doi.org/10.1186/1741-7015-11-174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3734216/
https://www.ncbi.nlm.nih.gov/pubmed/23902720
http://dx.doi.org/10.1186/1741-7015-11-174

Ejemplares similares